IC51 Japanese Encephalitis vaccine

Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO®]

(2009) Sean T. Duggan et al.   DRUGS

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study

(2009) Elisabeth Schuller et al.   VACCINE

Japanese encephalitis vaccine in travelers

(2008) Tomas Jelinek   Expert Review of Vaccines

Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand

(2008) Ville A. Lehtinen et al.   JOURNAL OF CLINICAL VIROLOGY

Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Trial of the Safety and Tolerability of IC51, an Inactivated Japanese Encephalitis Vaccine

(2008) E. Tauber et al.   JOURNAL OF INFECTIOUS DISEASES

Pathogenic flaviviruses

(2008) EA Gould et al.   LANCET

New vaccines for Japanese encephalitis

(2008) Tom Solomon   LANCET NEUROLOGY

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

(2008) E. Schuller et al.   VACCINE

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51

(2008) Elisabeth Schuller et al.   VACCINE

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

(2008) Salvacion Gatchalian et al.   VACCINE